Contact this trialFirst, we need to learn more about you.
Mesenchymal Stem Cell
Cord Blood-Derived Mesenchymal Stem Cells for Blood Cancers
Recruiting1 awardPhase 1 & 2
Houston, Texas
This trial will test whether it is feasible to use cord blood-derived mesenchymal stem cells (MSCs) to treat patients with acute respiratory distress syndrome (ARDS) related to COVID-19 infection. If it is successful, a larger trial will be conducted to compare the effect of MSCs with standard of care in these patients.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service